Ipca Laboratories Ltd

Ipca Labs. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ipca Laboratories Ltd

₹ 1,425 -3.07%
30 May - close price
ipca.com BSE: 524494 NSE: IPCALAB
About

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)

Key Points

Integrated nature of operations
Ipca Laboratories is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. [1]
IPCA is among India’s top 20 pharmaceutical companies. [2]

Business segments FY22:
API Business (25%) [3]
Ipca produces over 80 APIs, nearly 79% of the APIs and Intermediates business is from exports making them one of India’s top exporters of APIs, serving over 100 countries around the globe. The core strategic focus has been on backward integration, resulting in superior supply chain reliability and cost competitiveness [4] [1] [5]

Website BSE NSE
  • Market Cap ₹ 36,148 Cr.
  • Current Price ₹ 1,425
  • High / Low ₹ 1,758 / 1,052
  • Stock P/E 43.3
  • Book Value ₹ 272
  • Dividend Yield 0.28 %
  • ROCE 17.6 %
  • ROE 12.6 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company has been maintaining a healthy dividend payout of 18.3%

Cons

  • Stock is trading at 5.25 times its book value
  • The company has delivered a poor sales growth of 9.01% over past five years.
  • Company has a low return on equity of 10.4% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 Nifty 500 BSE MidCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
1,178 1,478 1,495 1,440 1,402 1,486 1,663 1,507 1,511 1,566 1,811 1,663 1,638
996 1,223 1,224 1,229 1,226 1,189 1,314 1,234 1,218 1,213 1,409 1,252 1,280
Operating Profit 182 255 270 211 176 298 348 273 292 353 402 411 359
OPM % 15% 17% 18% 15% 13% 20% 21% 18% 19% 23% 22% 25% 22%
13 18 36 24 33 43 -3 17 -79 15 17 17 -260
Interest 3 7 9 10 18 31 39 27 24 19 17 10 16
Depreciation 54 55 56 58 59 60 61 63 62 61 63 63 65
Profit before tax 137 211 240 166 132 250 245 200 127 288 339 356 17
Tax % 20% 34% 31% 31% 36% 33% 34% 32% 49% 29% 28% 25% 479%
110 140 166 115 85 167 162 137 65 204 244 268 -65
EPS in Rs 4.34 5.52 6.53 4.54 3.34 6.57 6.39 5.40 2.55 8.05 9.62 10.55 -2.56
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3,235 3,088 2,804 3,102 3,193 3,606 4,338 5,114 5,405 5,775 6,124 6,678
2,498 2,556 2,526 2,666 2,748 2,909 3,419 3,596 4,164 4,858 4,909 5,153
Operating Profit 737 532 277 436 446 697 918 1,518 1,241 917 1,215 1,525
OPM % 23% 17% 10% 14% 14% 19% 21% 30% 23% 16% 20% 23%
21 32 26 19 39 54 64 61 53 108 -23 -210
Interest 28 29 31 26 27 21 19 11 10 46 123 63
Depreciation 101 177 161 171 174 172 179 188 210 229 246 252
Profit before tax 629 358 111 258 283 557 785 1,380 1,074 750 822 1,000
Tax % 24% 28% 17% 27% 18% 18% 17% 17% 20% 33% 35% 35%
477 256 93 188 233 455 652 1,141 860 506 530 651
EPS in Rs 18.91 10.15 3.67 7.46 9.24 18.00 25.82 44.97 33.91 19.93 20.91 25.65
Dividend Payout % 13% 5% 0% 7% 5% 8% 10% 9% 12% 20% 19% 16%
Compounded Sales Growth
10 Years: 8%
5 Years: 9%
3 Years: 7%
TTM: 9%
Compounded Profit Growth
10 Years: 13%
5 Years: 5%
3 Years: -1%
TTM: 39%
Stock Price CAGR
10 Years: 16%
5 Years: 13%
3 Years: 17%
1 Year: 24%
Return on Equity
10 Years: 13%
5 Years: 14%
3 Years: 10%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 25 25 25 25 25 25 25 25 25 25 25 25
Reserves 1,956 2,208 2,258 2,450 2,670 3,111 3,652 4,727 5,450 5,852 6,323 6,866
595 929 865 716 628 444 474 236 776 1,440 1,152 906
641 662 756 777 785 877 1,033 1,021 1,186 1,129 1,159 1,273
Total Liabilities 3,217 3,824 3,905 3,968 4,108 4,458 5,185 6,010 7,438 8,447 8,659 9,071
1,306 1,753 1,977 1,946 1,855 1,740 1,841 1,869 2,153 2,479 2,524 2,543
CWIP 165 267 129 95 73 66 84 182 297 123 175 484
Investments 29 82 97 212 216 322 649 868 1,339 1,057 2,654 2,693
1,717 1,722 1,702 1,716 1,964 2,329 2,611 3,092 3,650 4,789 3,306 3,351
Total Assets 3,217 3,824 3,905 3,968 4,108 4,458 5,185 6,010 7,438 8,447 8,659 9,071

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
515 455 696 271 324 496 561 1,096 832 762 831
-362 -686 -214 -146 -119 -123 -499 -560 -812 -710 -1,355
-138 255 -414 -156 -130 -223 -139 -307 426 506 -465
Net Cash Flow 14 25 68 -31 74 150 -76 229 446 559 -990

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 51 42 57 59 68 64 71 55 56 59 61 63
Inventory Days 271 293 290 288 286 332 312 350 364 293 309 297
Days Payable 109 97 145 128 136 146 133 121 101 80 78 93
Cash Conversion Cycle 213 238 203 219 218 250 250 284 319 272 293 268
Working Capital Days 98 107 86 95 109 113 117 123 130 123 123 142
ROCE % 27% 13% 4% 9% 9% 17% 20% 30% 19% 11% 14% 18%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
46.29% 46.29% 46.29% 46.29% 46.29% 46.29% 46.29% 46.30% 46.30% 46.30% 44.72% 44.72%
10.61% 10.57% 10.46% 10.58% 10.05% 9.86% 10.27% 10.51% 10.85% 10.83% 11.06% 10.75%
33.49% 33.46% 33.71% 33.74% 34.86% 34.72% 34.19% 34.05% 33.46% 33.90% 35.36% 35.73%
0.24% 0.32% 0.32% 0.32% 0.32% 0.32% 0.32% 0.32% 0.32% 0.32% 0.32% 0.32%
9.37% 9.34% 9.22% 9.06% 8.46% 8.80% 8.93% 8.82% 9.07% 8.64% 8.53% 8.45%
No. of Shareholders 1,10,8181,11,0431,08,1771,10,29699,88995,93082,80981,16584,75382,97590,18988,306

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls